Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “THROMBOTIC MICROANGIOPATHY”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT01443351
What this trial is testing

Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Zealand University Hospital
Testing effectiveness (Phase 2)Study completedNCT02153060
What this trial is testing

An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Shandong University 58
Not applicableLooking for participantsNCT04745195
What this trial is testing

Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium

Who this might be right for
Thrombotic MicroangiopathiesHemolytic Uremic Syndrome, AtypicalHemolytic-Uremic Syndrome
Maastricht University Medical Center 42
Large-scale testing (Phase 3)Ended earlyNCT00799773
What this trial is testing

Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Carelon Research 3
Large-scale testing (Phase 3)WithdrawnNCT01433003
What this trial is testing

The Plasma Large-Volume Exchange RCT

Who this might be right for
Purpura, Thrombotic ThrombocytopenicHemolytic Uremic Syndrome
London Health Sciences Centre
Testing effectiveness (Phase 2)Study completedNCT00128882
What this trial is testing

Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D

Who this might be right for
Idiopathic Thrombocytopenic Purpura
University of Aarhus 45
Testing effectiveness (Phase 2)Looking for participantsNCT06992128
What this trial is testing

Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 129
Testing effectiveness (Phase 2)Ended earlyNCT00953771
What this trial is testing

Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Icahn School of Medicine at Mount Sinai 9
Testing effectiveness (Phase 2)Study completedNCT00424177
What this trial is testing

Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 66
Large-scale testing (Phase 3)Active Not RecruitingNCT05653219
What this trial is testing

Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids

Who this might be right for
Primary Immune Thrombocytopenia
Novartis Pharmaceuticals 152
Not applicableStudy completedNCT00199628
What this trial is testing

Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization

Who this might be right for
Glomerulonephritis, MembranousNeonatal Diseases and AbnormalitiesHemochromatosis
University Hospital, Limoges 100
Testing effectiveness (Phase 2)Looking for participantsNCT07362199
What this trial is testing

Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)WithdrawnNCT06176235
What this trial is testing

Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital
Not applicableNot Yet RecruitingNCT07798050
What this trial is testing

Selective Mediterranean Diet in Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaIdiopathic Thrombocytopenic PurpuraThrombocytopenia
Assiut University 60
Not applicableStudy completedNCT03219723
What this trial is testing

Drug Use Surveillance of Takecab for "Supplement to Helicobacter Pylori Eradication"

Who this might be right for
Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other
Takeda 560
Not applicableLooking for participantsNCT07353099
What this trial is testing

A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
Takeda 50
Testing effectiveness (Phase 2)Looking for participantsNCT07063199
What this trial is testing

Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Not applicableUnknownNCT04320225
What this trial is testing

Connection Between Vitamin D Level and the Efficacy of Dexamethasone in Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Shandong University 60
Large-scale testing (Phase 3)UnknownNCT03520049
What this trial is testing

Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Unity Health Toronto 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05504187
What this trial is testing

Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Kira Pharmacenticals (US), LLC. 24
Next Page